Status:
TERMINATED
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Schering-Plough
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The research hypothesis for the proposed study asks the question, can Asmanex® demonstrate comparable anti-inflammatory therapeutic efficacy to the combination product, Advair® in control of mild pers...
Eligibility Criteria
Inclusion
- subjects 18 to 65 years of age
- a \>2 year history of asthma
- FEV1 \> 80% for subjects currently using Advair®.
Exclusion
- severe asthma
- current smokers
- pregnant or breast-feeding women
- other chronic significant illnesses
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 19 2010
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00461812
Start Date
April 1 2007
End Date
January 19 2010
Last Update
September 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Asthma and Allergy Center
Baltimore, Maryland, United States, 21224